down arrow

Lifecore Biomedical, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US5147661046
USD
7.77
0.05 (0.65%)

Dec 04

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Assertio Holdings, Inc.
IGM Biosciences, Inc.
scPharmaceuticals, Inc.
Y-mAbs Therapeutics, Inc.
Ocular Therapeutix, Inc.
Vanda Pharmaceuticals, Inc.
AC Immune SA
Compass Therapeutics, Inc.
Lifecore Biomedical, Inc.
Inozyme Pharma, Inc.
Acumen Pharmaceuticals, Inc.
Why is Lifecore Biomedical, Inc. ?
Icon
Unrated Stock - No Analysis Available
stock-recommendationReal-Time Research Report
Verdict Report
Icon
No Data Found
Is Lifecore Biomedical, Inc. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Lifecore Biomedical, Inc.
4.02%
0.55
62.19%
S&P 500
13.22%
0.61
20.17%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-26.24%
EBIT Growth (5y)
-16.15%
EBIT to Interest (avg)
-0.51
Debt to EBITDA (avg)
7.25
Net Debt to Equity (avg)
2.48
Sales to Capital Employed (avg)
0.79
Tax Ratio
0.11%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
79.28%
ROCE (avg)
0.41%
ROE (avg)
0
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
5.35
EV to EBIT
-30.78
EV to EBITDA
-81.49
EV to Capital Employed
2.25
EV to Sales
2.85
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-7.31%
ROE (Latest)
-89.08%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

14What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD -0.2 MM

INVENTORY TURNOVER RATIO(HY)

Highest at 2.45 times

OPERATING PROFIT(Q)

Highest at USD 4.81 MM

OPERATING PROFIT MARGIN(Q)

Highest at 13.21 %

PRE-TAX PROFIT(Q)

Highest at USD -2.54 MM

NET PROFIT(Q)

Highest at USD -2.58 MM

EPS(Q)

Highest at USD -0.06

-10What is not working for the Company
NET PROFIT(HY)

At USD -16.86 MM has Grown at -85.28%

RAW MATERIAL COST(Y)

Grown by 16.19% (YoY

DEBTORS TURNOVER RATIO(HY)

Lowest at 3.44 times

Here's what is working for Lifecore Biomedical, Inc.
Operating Cash Flow
Highest at USD -0.2 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Operating Profit
Highest at USD 4.81 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (USD MM)

Operating Profit Margin
Highest at 13.21 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit
Highest at USD -2.54 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Pre-Tax Profit
At USD -2.54 MM has Grown at 75.96%
over average net sales of the previous four periods of USD -10.57 MM
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Net Profit
Highest at USD -2.58 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (USD MM)

Net Profit
At USD -2.58 MM has Grown at 75.62%
over average net sales of the previous four periods of USD -10.56 MM
MOJO Watch
Near term Net Profit trend is positive

Net Profit (USD MM)

EPS
Highest at USD -0.06
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Inventory Turnover Ratio
Highest at 2.45 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Here's what is not working for Lifecore Biomedical, Inc.
Debtors Turnover Ratio
Lowest at 3.44 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Raw Material Cost
Grown by 16.19% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."